Showing posts with label NSAIDS. Show all posts
Showing posts with label NSAIDS. Show all posts

Is oral or topical Diclofenac sodium better for muscle or joint pain?

Diclofenac sodium is a non-steroidal anti-inflammatory drug used to reduce inflammation and to reduce pain in conditions such as arthritis. Two routes of administration are available—oral as well as topical. The efficacy of oral non-steroidal anti-inflammatory drugs has been established for synovial (joint) and muscle tissue. However, there is little data available on the efficacy of topical NSAIDS. The results of a recent study published in the British Journal of Clinical Pharmacology (Miyatake et al, 2009) compared the concentration of diclofenac from topical and oral administration.

Dosages compared included a capsule containing 37.5mg of diclofenac sodium vs. 2 tapes containing 30mg of diclofenac sodium for topical application. Concentrations of diclofenac were measured in muscle, synovial membrane, and plasma 12 hours following administration.

Results: The diclofenac concentration was significantly higher in the muscle after topical application compared to oral administration (measured 12h after dosage). However, the concentrations in the synovial membrane was significantly lower after topic administration compared to oral administration. There were no significant differences in plasma diclofenac levels between either route of administration.

Conclusions: The results of this study suggest that topical administration of diclofenac sodium may actually be better for muscle pain. In contrast, these study results suggest that oral diclophanc sodium may be a better route of administration for people with joint pain or arthritis.

Side effects of Diclofenac sodium (among others)


  1. Cardiac—potential increased risk of heart disease/myocardial infarction
  2. Gastrointestinal—ulcers/bleeding.
  3. Liver—damage/hepatitis
  4. Kidney—adverse kidney effects
  5. Other—bone marrow depression, affects blood clotting
    Reference:
    Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol. 2009 Jan;67(1):125-9.

    How to advise aspirin use in patients who need NSAIDs.


    Many patients who suffer from osteoarthritis taken prescription NSAIDS to treat their condition. NSAIDs carry a significant risk of gastrointestinal bleeding. Selective Cox-2 inhibitors are believed to have a lower risk of GI bleeding, but carry a risk of serious thrombotic events.


    Low dose Aspiring is used by many patients fr the prevention of cardiovascular events. At present, it is STILL UNKNOWN whether aspririn lowers the risk of cardiovascular events in patients who are taking selective COx-2 inhibitors...


    "NSAIDs are widely used all over the world. NSAID use is rising due to increasing availability without a prescription, use of aspirin for prevention of thrombotic disorders and the ageing population. Aspirin is used as an analgesic drug in many countries, but the main current indication is low-dose aspirin for the prevention of cardiovascular events. However, NSAIDs and aspirin use account for approximately 20-25% of all reported drug adverse events. Most of those are gastrointestinal including dyspepsia, hemorrhage, perforation and even death. The COX-2- selective inhibitors (coxibs) have demonstrated equivalent efficacy to nonspecific NSAIDs in the management of arthritis and pain but have less gastrointestinal adverse events, although coxibs and probably all NSAIDs, significantly increase risk of serious thromboembolic events.  

    Concomitant use of low-dose aspirin is present in more than 20% of all patients taking either NSAIDs or coxibs, thus increasing the risk of gastrointestinal side effects. Furthermore, at present, it is not known whether aspirin decreases the cardiovascular risks of COX-2 inhibitors or NSAIDs.

    Appropriate strategies for gastrointestinal risk reduction with NSAIDs and aspirin must consider the overall health status of our patients including the presence of cardiovascular and gastrointestinal risk factors. Use of the lowest possible dose of these drugs, gastroprotectants, especially proton pump inhibitors and Helicobacter pylori eradication will reduce the risk of gastrointestinal side effects in patients taking low-dose aspirin and NSAIDs or coxibs."


    Reference:
    Sopena F, Lanas A. How to advise aspirin use in patients who need NSAIDs. Curr Pharm Des. 2007;13(22):2248-60.

    How effective are NSAIDS for treating long-term pain relating to knee osteoarthritis?


    Do non-steroidal anti-inflammatory drugs effectively relieve arthritis pain?

    To answer this question, a recent study published in the European Journal of Pain looked at the effectiveness of NSAIDS in treating arthritis pain.
    "Clinical effects from pharmacological interventions in OAK are small and limited to the first 2-3 weeks after start of treatment. The pain-relieving effects over placebo in OAK are smaller than the patient-reported thresholds for relevant improvement (Bjordal JM, et. 2007)."
    Reference:

    Bjordal JM, Klovning A, Ljunggren AE, Slørdal L. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials. Eur J Pain.  2007 Feb;11(2):125-38. Epub 2006 May 8.


    In this study which included over 14,000 patients, they concluded that NSAIDS or non-steroidal anti-inflammatory drugs offer limited pain relief in comparison to a placebo after the first month of treatment. This suggests that long term pain management in patients with osteoarthritis of their knee will be difficult to manage with NSAIDS alone.


    *Please refer to this blog's disclaimer text.